Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Enrolling by invitation × Plasma cell × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Completed 501 Terminated 138 Active not recruiting 114 Recruiting 101 Unknown 65 Withdrawn 60 Not yet recruiting 21 Suspended 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11 Breast 10 Lymphoid 9 Thoracic 5 Other hematologic neoplasm 4 Head & Neck 3 Genitourinary 3 NET 2 Myeloid 2 Gynecologic 2 Endocrine 2 CNS 2 Sarcoma 1 Plasma cell 1 Other 1 Dermatologic 1

Conditions

Multiple Myeloma 1 Lymphoma, T-Cell 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03628612 2025-08-07

Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells

Autolus Limited

Phase 2 Enrolling by invitation

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡